This site is intended for US audiences only.

EMPLICITI is a prescription medicine used to treat multiple myeloma in combination with the medicines:

  • REVLIMID® (lenalidomide) and dexamethasone in adults who have received one to three prior treatments for their multiple myeloma.
  • POMALYST® (pomalidomide) and dexamethasone in adults who have received at least two prior treatments including REVLIMID and a proteasome inhibitor.

It is not known if EMPLICITI, REVLIMID, or POMALYST is safe and effective in children.